PMID- 36740184 OWN - NLM STAT- MEDLINE DCOM- 20230424 LR - 20230424 IS - 1525-2191 (Electronic) IS - 0002-9440 (Linking) VI - 193 IP - 5 DP - 2023 May TI - TRPV1 Dysfunction Impairs Gastric Nitrergic Neuromuscular Relaxation in High-Fat Diet-Induced Diabetic Gastroparesis Mice. PG - 548-557 LID - S0002-9440(23)00037-8 [pii] LID - 10.1016/j.ajpath.2023.01.005 [doi] AB - Diabetic gastroparesis (DGP) is characterized by delayed gastric emptying of solid food. Nitrergic neuron-mediated fundus relaxation and intragastric peristalsis are pivotal for gastric emptying and are impaired in DGP. Transient receptor potential vanilloid 1 (TRPV1) ion channels are expressed in gastrointestinal vagal afferent nerves and have a potential role in relevant gastrointestinal disorders. In this study, mice with high-fat diet (HFD)-induced type 2 diabetes mellitus (T2DM), associated with gastroparesis, were used to determine the role of TRPV1 in DGP. After feeding with HFD, mice exhibited obesity, hyperglycemia, insulin resistance, and delayed gastric emptying. Cholinergic- and nitrergic neuron-mediated neuromuscular contractions and relaxation were impaired. The antral tone of the DGP mice was attenuated. Interestingly, activating or suppressing TRPV1 facilitated or inhibited gastric fundus relaxation in normal mice. These effects were neutralized by using a nitric oxide synthase (NOS) inhibitor. Activation or suppression of TRPV1 also increased or reduced NO release. TRPV1 was specifically localized with neuronal NOS in the gastric fundus. These data suggest that TRPV1 activation facilitates gastric fundus relaxation by regulating neuronal NOS and promoting NO release. However, these effects and mechanisms disappeared in mice with DGP induced by HFD diet. TRPV1 expression was only marginally decreased in the fundus of DGP mice. TRPV1 dysfunction may be a potential mechanism underlying the dysfunction of DGP gastric nitrergic neuromuscular relaxation. CI - Copyright (c) 2023 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. FAU - Xu, Siyuan AU - Xu S AD - School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China; Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China. FAU - Liang, Shaochan AU - Liang S AD - School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. FAU - Pei, Ying AU - Pei Y AD - School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. FAU - Wang, Rui AU - Wang R AD - School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. FAU - Zhang, Yao AU - Zhang Y AD - School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. FAU - Xu, Yifei AU - Xu Y AD - Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China. FAU - Huang, Bin AU - Huang B AD - Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China. FAU - Li, Haiwen AU - Li H AD - Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China. FAU - Li, Juanjuan AU - Li J AD - Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China. FAU - Tan, Bo AU - Tan B AD - School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. FAU - Cao, Hongying AU - Cao H AD - School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: hycao@gzucm.edu.cn. FAU - Guo, Shaoju AU - Guo S AD - Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China. Electronic address: gsj1080@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230203 PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 0 (TRPV1 protein, mouse) RN - 0 (TRPV Cation Channels) SB - IM MH - Mice MH - Animals MH - *Gastroparesis/etiology/metabolism MH - *Diabetes Mellitus, Type 2/complications MH - Diet, High-Fat/adverse effects MH - Obesity/metabolism MH - Gastric Emptying MH - TRPV Cation Channels/metabolism EDAT- 2023/02/06 06:00 MHDA- 2023/04/24 06:42 CRDT- 2023/02/05 19:28 PHST- 2022/10/12 00:00 [received] PHST- 2022/12/30 00:00 [revised] PHST- 2023/01/06 00:00 [accepted] PHST- 2023/04/24 06:42 [medline] PHST- 2023/02/06 06:00 [pubmed] PHST- 2023/02/05 19:28 [entrez] AID - S0002-9440(23)00037-8 [pii] AID - 10.1016/j.ajpath.2023.01.005 [doi] PST - ppublish SO - Am J Pathol. 2023 May;193(5):548-557. doi: 10.1016/j.ajpath.2023.01.005. Epub 2023 Feb 3.